Janssen: FDA grants accelerated approval for SIRTURO™ (bedaquiline) as part of combination therapy to treat adults with pulmonary MDR-TB

SIRTURO™ was discovered by researchers at Janssen and is currently under review by three regulatory bodies including the European Medicines Agency (EU), State Food and Drug Administration (China) and Medicines Control Council (South Africa).

Read the press release here.

Source: Janssen Therapeutics